DR SIMS AND PARTNERS — All Prescriptions & Medications — Page 9
Practice Code: Y00469 | BASILDON, SS13 3HQ
Showing results 401-450 of 660
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Celecoxib | 43 | 2,462 | £122 | -34.9% ▼ |
| Miconazole nitrate | 42 | 1,335 | £212 | -40.6% ▼ |
| 42 | 1,205 | £2.8K | +347.0% ▲ | |
| Lofepramine hydrochloride | 41 | 4,116 | £1.8K | +37.1% ▲ |
| Ferrous gluconate | 41 | 2,016 | £58 | -14.3% ▼ |
| Dexamethasone sodium metasulphobenzoate | 41 | 328 | £293 | +451.6% ▲ |
| 41 | 293 | £852 | +69.6% ▲ | |
| Olmesartan medoxomil/hydrochlorothiazide | 40 | 1,484 | £709 | +303.5% ▲ |
| Fluvoxamine maleate | 40 | 2,400 | £1.0K | +229.0% ▲ |
| Brivaracetam | 40 | 10.6K | £7.2K | +17.6% ▲ |
| Emollient bath and shower preparations | 40 | 20.7K | £220 | -36.3% ▼ |
| 40 | 1,323 | £220 | +1.5% vs avg | |
| 40 | 860 | £618 | +118.2% ▲ | |
| 40 | 516 | £1.0K | +7.8% ▲ | |
| 40 | 4,500 | £261 | -2.3% ▼ | |
| Moxonidine | 39 | 1,288 | £174 | -29.9% ▼ |
| Ondansetron hydrochloride | 39 | 1,530 | £978 | -19.6% ▼ |
| Oxcarbazepine | 39 | 2,632 | £874 | +39.5% ▲ |
| Meloxicam | 39 | 1,148 | £32 | -41.0% ▼ |
| Terbinafine hydrochloride | 39 | 1,039 | £200 | +5.1% ▲ |
| 39 | 450 | £1.1K | +86.7% ▲ | |
| Imipramine hydrochloride | 38 | 5,656 | £207 | +49.1% ▲ |
| Safinamide | 38 | 1,140 | £2.5K | +88.6% ▲ |
| 38 | 18.1K | £901 | -0.3% vs avg | |
| Terbutaline sulphate | 37 | 44 | £347 | -31.8% ▼ |
| 37 | 878 | £159 | +10.9% ▲ | |
| Glycerol | 36 | 474 | £79 | +2.6% ▲ |
| Naloxegol | 36 | 1,036 | £1.8K | +161.0% ▲ |
| Betamethasone sodium phosphate | 36 | 360 | £195 | +39.0% ▲ |
| Tamsulosin and dutasteride hydrochloride | 35 | 1,260 | £635 | +0.1% vs avg |
| Mercaptopurine | 35 | 1,237 | £569 | +126.0% ▲ |
| 35 | 394 | £378 | +236.9% ▲ | |
| Umeclidinium bromide | 34 | 34 | £889 | -44.8% ▼ |
| Ethosuximide | 34 | 9,984 | £11.2K | +130.5% ▲ |
| Potassium chloride | 34 | 1,980 | £199 | +81.9% ▲ |
| Urea | 34 | 13.8K | £410 | -49.1% ▼ |
| 34 | 90 | £713 | -50.4% ▼ | |
| Nizatidine | 33 | 1,350 | £1.4K | -4.1% ▼ |
| Sodium picosulfate | 33 | 9,500 | £828 | -9.1% ▼ |
| Acrivastine | 33 | 2,304 | £673 | +167.9% ▲ |
| Guanfacine | 33 | 924 | £2.0K | +28.4% ▲ |
| Mycophenolate mofetil | 33 | 3,586 | £1.2K | -18.5% ▼ |
| Fluorometholone | 33 | 165 | £54 | +129.1% ▲ |
| Zinc oxide | 32 | 10.4K | £297 | +59.1% ▲ |
| 32 | 1,890 | £5.4K | +116.3% ▲ | |
| Testosterone esters | 31 | 31 | £73 | +110.2% ▲ |
| Cabergoline | 31 | 568 | £968 | +99.9% ▲ |
| Timolol and travoprost | 31 | 93 | £363 | -4.1% ▼ |
| Methenamine hippurate | 30 | 1,980 | £523 | -67.0% ▼ |
| Etonogestrel | 30 | 30 | £2.5K | +3.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.